You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR INFUGEM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for INFUGEM

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04727242 ↗	CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma	Recruiting	Stanford University	Phase 2	2021-01-28	The purpose of this study is to find out if giving a dose of heated chemotherapy in the abdomen immediately after surgery that is done to remove uterine leiomyosarcoma type of cancer will help lower the risk of the cancer coming back in the future.
NCT05092360 ↗	Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab	Not yet recruiting	Merck Sharp & Dohme Corp.	Phase 3	2021-11-01	This is a Phase 3, multicenter, open-label, randomized study of nemvaleukin in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
NCT05092360 ↗	Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab	Not yet recruiting	Alkermes, Inc.	Phase 3	2021-11-01	This is a Phase 3, multicenter, open-label, randomized study of nemvaleukin in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for INFUGEM

Condition Name

Chart
Table

Condition Name for INFUGEM
Intervention	Trials
Fallopian Tube Cancer	1
LMS - Leiomyosarcoma	1
Platinum-resistant Ovarian Cancer	1
Primary Peritoneal Cancer	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for INFUGEM
Intervention	Trials
Carcinoma, Ovarian Epithelial	1
Leiomyosarcoma	1
Ovarian Neoplasms	1
Fallopian Tube Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for INFUGEM

Trials by Country

Map
Table

Trials by Country for INFUGEM
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for INFUGEM
Location	Trials
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for INFUGEM

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for INFUGEM
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for INFUGEM
Clinical Trial Phase	Trials
Not yet recruiting	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for INFUGEM

Sponsor Name

Chart
Table

Sponsor Name for INFUGEM
Sponsor	Trials
Stanford University	1
Merck Sharp & Dohme Corp.	1
Alkermes, Inc.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for INFUGEM
Sponsor	Trials
Industry	2
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.